Current understanding of modulated electro-hyperthermia in cancer treatment
- Author:
Sungmin KIM
1
;
Jesang YU
;
Jihun KANG
;
Yunkyung KIM
;
Taek Yong KO
Author Information
- Publication Type:Review article
- From:Kosin Medical Journal 2024;39(3):160-168
- CountryRepublic of Korea
- Language:English
- Abstract: Traditional hyperthermia involves increasing the temperature at the tumor site to above 39 ℃, inducing death in cancer cells. Although hyperthermia is an effective cancer treatment, its clinical application has decreased due to potential complications, including damage to surrounding normal tissue. In recent years, modulated electro-hyperthermia (mEHT) has emerged as an effective and safe treatment modality. mEHT selectively heats tumor cells to 42–43 °C, while reducing the average temperature in the treatment area, including the surrounding normal tissue, compared to conventional methods. Additionally, mEHT may be used in combination with systemic chemotherapy and radiation therapy in tumor treatment, providing a synergistic effect to increase efficacy. As chemotherapy and radiation therapy technologies advance, the application of combined mEHT may improve clinical outcomes. In this study, we review and discuss reports on the clinical outcomes of mEHT combined with chemotherapy and/or radiation therapy, which are established anticancer treatments.
